Loading…
Antianginal drugs NARRATED animation1970-01-01T00:00:00+00:00Rational for treatment and prevention of angina. Mechanisms of action of beta-blockers, calcium channel blockers, and organic nitrates.PT177Shttps://d38zjy0x98992m.cloudfront.net/9c278a25-24a5-4c66-8f8a-cd4693efd350/antianginal_drugs_xlarge.jpghttps://d38zjy0x98992m.cloudfront.net/9c278a25-24a5-4c66-8f8a-cd4693efd350/antianginal_drugs_mp4_hd_video.mp4
-- / 05:20hd
Anticoagulant drugs NARRATED animation
Overview of coagulation control. Mechanisms of action of heparin, low-molecular-weight heparin (LMWH), warfarin (vitamin K antagonist), and direct oral anticoagulants.
Duration: 05:20
© Alila Medical Media
Video resolution: 1920x1080 pixels @ 25.0 fps, ~1.8 Mbits/s
Anticoagulant drugs NARRATED animation2023-02-24T21:44:41ZOverview of coagulation control. Mechanisms of action of heparin, low-molecular-weight heparin (LMWH), warfarin (vitamin K antagonist), and direct oral anticoagulants.PT320Shttps://d38zjy0x98992m.cloudfront.net/1284b3a3-a4a2-4910-a479-581d1208e4d5/anticoagulants_xlarge.jpghttps://d38zjy0x98992m.cloudfront.net/1284b3a3-a4a2-4910-a479-581d1208e4d5/anticoagulants_mp4_hd_video.mp4
Pharmacology: Thrombolytic (Fibrinolytic) Drugs NARRATED Animation1970-01-01T00:00:00+00:00Thrombolytic therapy - mechanism of action. Fibrin-specific agents: tissue plasminogen activator (tPA), alteplase, reteplase, tenecteplase; and non–fibrin-specific agents: urokinase (uPA), streptokinase and anistreplase.PT248Shttps://d38zjy0x98992m.cloudfront.net/6357a9c8-f7dd-4a70-b4b9-66f0021fc9b4/thrombolytic_drugs_xlarge.jpghttps://d38zjy0x98992m.cloudfront.net/6357a9c8-f7dd-4a70-b4b9-66f0021fc9b4/thrombolytic_drugs_mp4_hd_video.mp4